154 related articles for article (PubMed ID: 7692118)
1. [Clinical and molecular aspects of peroxisome-deficient disorders].
Suzuki Y; Shimozawa N; Orii T
Nihon Rinsho; 1993 Sep; 51(9):2353-8. PubMed ID: 7692118
[TBL] [Abstract][Full Text] [Related]
2. [Human peroxisome-deficient disorders and pathogenic gene].
Fujiki Y
Rinsho Shinkeigaku; 1994 Dec; 34(12):1219-21. PubMed ID: 7539728
[TBL] [Abstract][Full Text] [Related]
3. Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect.
Shimozawa N; Suzuki Y; Orii T; Moser A; Moser HW; Wanders RJ
Am J Hum Genet; 1993 Apr; 52(4):843-4. PubMed ID: 7681622
[No Abstract] [Full Text] [Related]
4. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders].
Suzuki Y
No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633
[TBL] [Abstract][Full Text] [Related]
5. [Molecular biology of peroxisome biogenesis].
Fujiki Y
Nihon Rinsho; 1993 Sep; 51(9):2336-42. PubMed ID: 8411711
[TBL] [Abstract][Full Text] [Related]
6. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I.
Tamura S; Okumoto K; Toyama R; Shimozawa N; Tsukamoto T; Suzuki Y; Osumi T; Kondo N; Fujiki Y
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4350-5. PubMed ID: 9539740
[TBL] [Abstract][Full Text] [Related]
7. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ
J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
[TBL] [Abstract][Full Text] [Related]
8. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.
Moser AB; Rasmussen M; Naidu S; Watkins PA; McGuinness M; Hajra AK; Chen G; Raymond G; Liu A; Gordon D
J Pediatr; 1995 Jul; 127(1):13-22. PubMed ID: 7541833
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the peroxin Pex26p responsible for peroxisome biogenesis disorders of complementation group 8 impair its stability, peroxisomal localization, and interaction with the Pex1p x Pex6p complex.
Furuki S; Tamura S; Matsumoto N; Miyata N; Moser A; Moser HW; Fujiki Y
J Biol Chem; 2006 Jan; 281(3):1317-23. PubMed ID: 16257970
[TBL] [Abstract][Full Text] [Related]
10. Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction.
Tamura S; Matsumoto N; Imamura A; Shimozawa N; Suzuki Y; Kondo N; Fujiki Y
Biochem J; 2001 Jul; 357(Pt 2):417-26. PubMed ID: 11439091
[TBL] [Abstract][Full Text] [Related]
11. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.
Matsumoto N; Tamura S; Furuki S; Miyata N; Moser A; Shimozawa N; Moser HW; Suzuki Y; Kondo N; Fujiki Y
Am J Hum Genet; 2003 Aug; 73(2):233-46. PubMed ID: 12851857
[TBL] [Abstract][Full Text] [Related]
12. Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.
Honsho M; Tamura S; Shimozawa N; Suzuki Y; Kondo N; Fujiki Y
Am J Hum Genet; 1998 Dec; 63(6):1622-30. PubMed ID: 9837814
[TBL] [Abstract][Full Text] [Related]
13. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients.
Roscher AA; Hoefler S; Hoefler G; Paschke E; Paltauf F; Moser A; Moser H
Pediatr Res; 1989 Jul; 26(1):67-72. PubMed ID: 2475849
[TBL] [Abstract][Full Text] [Related]
14. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders.
Shimozawa N; Suzuki Y; Zhang Z; Imamura A; Toyama R; Mukai S; Fujiki Y; Tsukamoto T; Osumi T; Orii T; Wanders RJ; Kondo N
Hum Mol Genet; 1999 Jun; 8(6):1077-83. PubMed ID: 10332040
[TBL] [Abstract][Full Text] [Related]
15. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels.
Walter C; Gootjes J; Mooijer PA; Portsteffen H; Klein C; Waterham HR; Barth PG; Epplen JT; Kunau WH; Wanders RJ; Dodt G
Am J Hum Genet; 2001 Jul; 69(1):35-48. PubMed ID: 11389485
[TBL] [Abstract][Full Text] [Related]
16. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.
Yajima S; Suzuki Y; Shimozawa N; Yamaguchi S; Orii T; Fujiki Y; Osumi T; Hashimoto T; Moser HW
Hum Genet; 1992 Mar; 88(5):491-9. PubMed ID: 1372585
[TBL] [Abstract][Full Text] [Related]
17. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome.
Shimozawa N; Tsukamoto T; Suzuki Y; Orii T; Fujiki Y
J Clin Invest; 1992 Nov; 90(5):1864-70. PubMed ID: 1430210
[TBL] [Abstract][Full Text] [Related]
18. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
19. [Molecular analysis of peroxisomal disorders].
Shimozawa N
No To Hattatsu; 1998 Mar; 30(2):128-33. PubMed ID: 9545777
[TBL] [Abstract][Full Text] [Related]
20. [Peroxisomes and peroxisomal diseases].
Petelenz M; Gonciarz Z; Grzybek H; Panz B
Postepy Hig Med Dosw; 1991; 45(1-2):77-99. PubMed ID: 1717967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
